Emerson Electric Co. (EMR) 2024 10-K Earnings Analysis
Emerson Electric Co.2024 Earnings Analysis
79/100
Emerson Electric Co.'s FY2024 10-K for the period ended September 30, 2024 is easiest to read through $17.5B of revenue, $1.97B of net income, and $2.91B of free cash flow. AspenTech Majority Stake, Process Automation Install Base, and AspenTech Industrial Software remain the clearest way to understand where the economics come from and why margin durability looks different here than it would at a generic peer. Gross margin was 50.8% and operating margin was 0.0%, so FY2024 does not look like a year bought with weak pricing or loose cost control. The next test is whether management can hold onto today's economics as the business mix and end markets move around it.
Filing analysis
Emerson Electric Co. 2024 10-K Analysis
This page reads Emerson Electric Co.'s 2024 10-K annual report through the EarningsMoat framework: earnings quality, economic moat strength, capital allocation, and key risks. The current overall score is 79/100, or grade C.
EMR Earnings Quality
The earnings-quality module scores 82/100, with Gross Margin: 50.8%, Operating Margin: ~18%. The core question is whether reported profit is backed by operating cash flow and recurring business economics. See the earnings quality analysis guide.
EMR Economic Moat Analysis
The moat-strength module scores 85/100, with Process Automation Install Base: DeltaV + Ovation, AspenTech Industrial Software: Process simulation. The test is whether the advantage can protect returns after competitors react. Read the economic moat analysis guide.
EMR Free Cash Flow vs Net Income
CF/Net Income: 1.69x is the fastest read on whether accounting earnings turn into cash. The capital-allocation module scores 80/100. For the diagnostic, start with cash flow vs net income.
EMR Key Risks from the Annual Report
The risk module scores 70/100, with Process Industry Capex: Cycle-linked, AspenTech Integration: Multi-year. The goal is to separate ordinary disclosure from risks that can change margins, cash flow, leverage, or the moat itself.
Is EMR a High Quality Earnings Stock?
Based on this 2024 filing, EMR passes the first screen for high-quality earnings: the overall grade is C, and the earnings-quality score is 82/100. This is a research screen, not investment advice.
Read the report first
Understand Emerson Electric Co. first, then decide if it belongs on your watchlist
The EMR score, explanation, management facts, and filing sources are all here. When you want to follow more companies, review new-filing changes, or keep notes for the next review, keep more names in your watchlist.
Read the report first
Understand the company first. Keep up with every filing as your list grows.
A single report helps you judge one company. As your watchlist grows, review score, cash flow, moat, and risk changes together instead of repeating the same work.
Keep more names together
When your list grows, keep EMR with the rest of your names and review score, grade, and risk changes over time.
See how to track more namesAsk follow-up questions
Dig into cash conversion, moat evidence, capital allocation, and risk changes without rereading the full 10-K.
Ask a questionExport and revisit records
Save the EMR report as research notes you can revisit before the next filing.
Save research notesCore Dimension Scores
Evaluating competitive strength across earnings quality, moat strength, and risk sustainability
Earnings Quality
Per the fiscal 2024 10-K income statement, gross margin of 50.8% reflects the post Climate Technologies divestiture process automation and industrial software cost structure per the segment footnote.
Per the fiscal 2024 10-K income statement, operating margin reflects the integration period for AspenTech and National Instruments plus the disclosed operational-restructuring actions tied to the Climate Technologies divestiture wind-down.
Per the fiscal 2024 cash flow statement, OCF of $3.3B is 1.69x net income of $1.97B — the spread reflects acquisition-intangible amortization on AspenTech and National Instruments plus standard depreciation.
Per the FY2024 10-K post Climate Technologies divestiture business description, Emerson's portfolio now centers on Final Control (valves, actuators, regulators), Measurement & Analytical (sensors, gas chromatography), Discrete Automation, Control Systems & Software (DeltaV, Ovation, AspenTech), and AspenTech (industrial-software) per the segment disclosures.
FY2024 10-K shows $1.97B of net income on $17.5B of revenue, but the cleaner read is the $3.33B of operating cash flow that turned into $2.91B of free cash flow. AspenTech Majority Stake and Process Automation Install Base help explain why the margin profile stayed where it did instead of collapsing with every demand wobble. Operating margin landed at 0.0%, while capex ran at 2.4% of revenue. Reported profit is converting into cash at a healthy rate, which reduces the odds that the FY2024 result is being flattered by accruals.
Moat Strength
Per the FY2024 Control Systems & Software segment disclosures, Emerson's DeltaV (process automation system) and Ovation (power and water automation) installed base is deeply embedded in process-industry customer sites — multi-decade switching friction as described in the customer-relationship economics.
Per the 2022 announcement and 2023 close of the AspenTech majority-stake acquisition (per the closing press release), AspenTech's process-simulation, optimization, and asset performance management software products complement Emerson's process-automation hardware portfolio.
Per the FY2024 Final Control and Measurement & Analytical segment disclosures, Emerson's valve, actuator, regulator, and sensor products are typically specified by engineering firms into process-industry capital projects (chemicals, refining, LNG, power) — the specifications-anchored sales cycle creates structural design-in customer relationships.
Goodwill of $18.1B on $44B assets equals 40.8% per the fiscal 2024 balance sheet — reflecting the AspenTech majority-stake acquisition (2022 / 2023 per the close) plus the 2023 National Instruments acquisition (~$8.2B per the closing press release).
The competitive position starts with AspenTech Majority Stake and Process Automation Install Base, not with a vague appeal to scale. AspenTech Industrial Software and Final Control + Measurement matter because they deepen switching friction, expand installed-base economics, or widen route to market reach. FY2024 ROE was 9.1%, but the more important check is that cash generation and margins still support the operating story. That does not make the business immune; it means the next competitor has to overcome a functioning operating system rather than just a familiar name.
Capital Allocation
Per the fiscal 2024 cash flow statement, FCF of $2.9B (OCF $3.3B minus capex $0.42B) supports the multi-decade dividend-increase record disclosed in the dividend-history section.
Per the fiscal 2024 dividend-history disclosure and S&P Dividend Aristocrat index-membership criteria, Emerson has raised its dividend for more than 60 consecutive years — qualifying for Dividend King designation per the conventional index-screening rules.
$0.42B capex on $17.5B revenue equals 2.4% — disciplined for a process automation and industrial software operator. Capex funds R&D-facilities and manufacturing per the property and equipment footnote.
Per the FY2024 10-K and successive M&A disclosures, Emerson has completed a multi-year portfolio-reshaping program: divested Climate Technologies (HVAC compressors and other businesses sold to a Blackstone-led JV per the closing announcement), acquired the AspenTech majority stake (2023), and acquired National Instruments (2023). The reshaped portfolio centers on process automation and industrial software.
$2.91B of free cash flow is the starting point for the capital-allocation discussion, because it defines how much room management actually had after funding the business. Capex intensity is light at 2.4% of revenue, so the real allocation decision is what management does with the cash left after maintaining the platform. $3.59B of cash against $7.69B of debt means the balance sheet depends on steady cash generation rather than on idle liquidity. The dividend remains the primary recurring commitment, which makes payout coverage more important than headline EPS.
Key Risks
Per the fiscal 2024 Risk Factors, process-automation customer demand depends on chemicals, refining, LNG, and power-generation capex cycles. Long-cycle capex projects can have multi-year construction and startup timelines per industry-analyst coverage.
Per the AspenTech-acquisition closing communications and successive segment disclosures, Emerson's integration of the AspenTech business (combining heritage AspenTech with Emerson's OSI Inc. and the prior Geological Simulation Software business) is a multi-year process. Integration progress is disclosed in successive earnings communications.
Per the fiscal 2024 balance sheet, $18.1B goodwill concentrates impairment risk on the AspenTech and National Instruments acquisition reporting units. Impairment testing follows the disclosed accounting-policy methodology.
Per the fiscal 2024 Discrete Automation segment MD&A, the National Instruments-anchored Test & Measurement business has cyclical exposure to semiconductor capex, automotive R&D, and industrial-test demand cycles as described in the customer end market mix.
The risk section is better read as a set of operating tradeoffs than as one binary red flag. Pressure in one part of the model can travel into margins and cash conversion faster than the headline score suggests. Goodwill is 40.8% of assets, so portfolio execution and acquisition discipline remain part of the risk discussion. The next test is whether management can hold onto today's economics as the business mix and end markets move around it.
Management
Ask about this section
Ask one question here. Keep digging when the issue needs more work.
This analysis is for educational purposes only and does not constitute investment advice.